Cody v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided November 4, 2021·No. 19-1013·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 19-1013V UNPUBLISHED

GLADYS CODY, Chief Special Master Corcoran

Petitioner, Filed: October 4, 2021 v. Special Processing Unit (SPU); Joint SECRETARY OF HEALTH AND Stipulation on Damages; Influenza HUMAN SERVICES, (Flu) Vaccine; Guillain-Barre Syndrome (GBS) Respondent.

John Graham Schultz, Leavy Shultz Davis, PS, Kennewick, WA, for Petitioner.

Adriana Ruth Teitel, U.S. Department of Justice, Washington, DC, for Respondent.

DECISION ON JOINT STIPULATION 1

On July 15, 2019, Gladys Cody filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq. 2 (the “Vaccine Act”). Petitioner alleges that she suffered Guillain-Barre Syndrome (GBS) as a result of her October 23, 2018 influneza (“flu”) vaccination. Petition at 1; Stipulation, filed at September 28, 2021, ¶¶ 1-2; 4. The case was assigned to the Special Processing Unit of the Office of Special Masters.

On June 10, 2020, a ruling on entitlement was issued, finding Petitioner entitled to compensation for GBS. On September 28, 2021, the parties filed the attached joint stipulation, stating that a decision should be entered awarding compensation. I find the stipulation reasonable and adopt it as my decision awarding damages, on the terms set forth therein.

1 Because this unpublished Decision contains a reasoned explanation for the action in this case, I am required to post it on the United States Court of Federal Claims' website in accordance with the E- Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Pursuant to the terms stated in the attached Stipulation, I award the following compensation:

a. An amount sufficient to purchase the annuity contract described in paragraph 10 of the parties’ Stipulation, paid to the life insurance company from which the annuity will be purchased (the "Life Insurance Company"); and

b. A lump sum of $437,290.87 in the form of a check payable to Petitioner. This amount represents compensation for all remaining damages that would be available under 42 U.S.C. §300aa-15(a), including $175,000.00 for pain and suffering, $184,883.95 for past unreimbursed medical expenses, and $77,406.92 for the first year of future unreimbursed medical expenses.

Stipulation at ¶ 8.

I approve the requested amount for Petitioner’s compensation. In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is directed to enter judgment in accordance with this decision. 3

IT IS SO ORDERED.

s/Brian H. Corcoran Brian H. Corcoran Chief Special Master

3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice renouncing the right to seek review. IN THE UNITED ST ATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS

GLADYS CODY,

Petitioner, No. l9-l013V v. Chief Special Master Corcoran (SPU) ECF SECRETARY OF HEAL TH AND HUMAN SERVICES,

Respondent.

STIPULATION

The parties hereby stipulate to the following matters:

I. Petitioner Gladys Cody ("petitioner") filed a petition for vaccine compensation under

the National Vaccine Injury Compensation Program, 42 U.S.C. §§ 300aa-l Oto -34 (the ''Vaccine

Program"). The petition seeks compensation for injuries allegedly related to petitioner's receipt

of an influenza ("flu') vaccine, which vaccine is contained in the Vaccine Injury Table (the

"Table"), 42 C.F.R. § I 00.3 (a).

2. Petitioner received her flu vaccination on October 23, 2018.

3. The vaccination was administered within the United States.

4. Petitioner sustained the onset of Guillain-Barre Syndrome ("GBS'') within the time

period set forth in the Table following administration of the flu vaccine, and experienced the

residual effects of her GBS for more than six months.

5. There is not a preponderance of the evidence demonstrating that petitioner's GBS and

its residual effects were due to a factor unrelated to this October 23, 2018 flu vaccine.

6. Petitioner represents that there has been no prior award or settlement of a civil action

I of7 for damages on her behalf as a result of her condition.

7. Accordingly, petitioner is entitled to compensation under the terms of the Vaccine

Program for her GBS Table injury. Therefore, a decision should be entered awarding the

compensation described in paragraph 8 of this Stipulation.

8. As soon as practicable after an entry of judgment reflecting a decision consistent with

the terms of this Stipulation, and after petitioner has filed an election to receive compensation

pursuant to 42 U.S.C. § 300aa-2l(a)(I), the Secretary of Health and Human Services will issue

the following vaccine compensation paymems:

a. An amount sufficient to purchase the annuity contract described in paragraph IO below, paid to the life insurance company from which the annuity will be purchased (the "Life Insurance Company"); 1 and

b. A lump sum of $437,290.87, in the form of a check payable to petitioner. This amount represents compensation for all remaining damages that would be available under 42 U.S.C. §300aa-l 5(a), including$ I 75,000.00 for pain and suffering,$ I 84,883.95 for past unreimbursed medical expenses, and $77,406.92 for the first year of future unreimbursed medical expenses.

9. The Life Insurance Company must have a minimum of $250,000,000 capital and

surplus, exclusive of any mandatory security valuation reserve. The Life Insurance Company

must have one of the following ratings from two of the following rating organizations:

a. A.M. Be::.t Comµany : A++, A :, A+g, A+p, /\+r, or J\+s;

b. Moody's Investor Service Claims Paying Rating: Aa3, Aa2, Aal, or Aaa;

c. Standard and Poor' s Corporation Insurer Claims-Paying Ability Rating: AA-, AA, AA+, or AAA;

1 Notwithstanding references herein to "the Life Insurance Company'' or "the annuity contract," to satisfy the conditions set forth herein, in respondent's sole and absolute discretion, respondent may purchase one or more annuity contracts from one or more life insurance companies.

2 of7 d.

Free access — add to your briefcase to read the full text and ask questions with AI

Cody v. Secretary of Health and Human Services, (uscfc 2021).

Cody v. Secretary of Health and Human Services (Cody v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

§ 300aa
42 U.S.C. § 300aa
§ 300aa-
42 U.S.C. § 300aa-
§ 300aa-10
42 U.S.C. § 300aa-10
§ 300aa-15
42 U.S.C. § 300aa-15(a)
§ 300aa-2l
42 U.S.C. § 300aa-2l(a)(I)
§ 300aa-l
42 U.S.C. § 300aa-l
Purposes
44 U.S.C. § 3501
§ 300a
42 U.S.C. § 300a